Rhon-klinikum Ag · XETR:RHK
Rhon-klinikum — H1 2019 Earnings Presentation
12 slides from Rhon-klinikum's earnings presentation, Aug 1, 2019
Slide 1: First Half-Year Results 2019
First Half-Year Results 2019 1 August 2019 RHÖN-KLINIKUM AG - First Quarter 2017 Results - as of May 5, 2017 1
Slide 2: Disclaimer
Disclaimer This presentation has been prepared by RHÖN-KLINIKUM AG (the “Company”) and is for information purposes only. This presentation does not constitute, or form part of, and should not be construed as, an offer, solicitation or invitation to subscribe for, underwrite or otherwise acquire, any
Slide 3: H1 2019 results Summary
H1 2019 results Summary RHÖN again performed better than the German hospital market “New Campus Bad Neustadt: First cross-sector care model for rural areas in Germany successfully Revenues increase by +3.9%; EBITDA by +19.2% implemented at the beginning of 2019” EBITDA margin at 9.5% (prior ye
Slide 4: Key P&L figures First half-year of 2019
Key P&L figures First half-year of 2019 Performance* vs. o H1 revenue growth of 3.9% in comparison to previous year impacted H1 2019 by additional charges from treatments of multiple sclerosis and cancer- in € millions H1 2018 immunotherapy (CART-Cell) as well as a new negotiation outcome for Revenu
Slide 5: Core balance sheet positions as of 30 June 2019
Core balance sheet positions as of 30 June 2019 €1,580m €1,580m RHÖN shows a strong financial solvency, solid balance sheet ratios... High Equity ratio of 74% 67% €1,056m Net Liquidity of €+71m Non-current assets Net Debt/EBITDA <0 €1,162m 74% Equity and a well coordinated multi-stage financia
Slide 6: Corporate strategy program: An excerpt of initiated measures (I)
Corporate strategy program An excerpt of initiated measures (I) Staffing initiatives We expanded our training capacities to counter HR market challenges New tariff agreements include attractive and competitive remuneration packages Focus curriculum “Digital Medicine, eHealth and Telemedicine”
Slide 7: Corporate strategy program: An excerpt of initiated measures (II)
Corporate strategy program An excerpt of initiated measures (II) Medical care models Unique Campus Concept as the future-model for cross-sectoral medical care in rural areas already in place at our Bad Neustadt site Roll-out of Campus Concept to identified cluster-regions in Germany planned Wi
Slide 8: Outlook 2019 Guidance confirmation
Outlook 2019 Guidance confirmation “In an unchanged difficult market environment, RHÖN succeeded in further increasing revenues, EBITDA and patient numbers despite regulatory hurdles and a shortage of specialists. Therefore RHÖN confirms its guidance for 2019.” – Stephan Holzinger, CEO/CFO GUIDANCE
Slide 9: Financial calendar for FY 2019
Appendix Financial calendar for FY 2019 1 August 2019 Publication of the half-year financial report as of 30 June 2019 8 November 2019 Publication of the interim report for the quarter ending 30 Sept 2019 Conference call All dates could be subject to modification RHÖN-KLINIKUM AG – Appendix 9
Slide 10: Price regulation in 2019 at a glance
Appendix Price regulation in 2019 at a glance Average base rate increase in states with RHÖN hospitals Federal Total hospital system budget (weighted by RHÖN case mix) Level Wage sum increase as main reference number for RHÖN effective base rate Benchmark (wage sum) 1 DRG inflation in 2019: +2.65%
Slide 11: Shareholder base
Appendix Shareholder base Shareholder structure as of 30 June 2019, according to the most recent notifications of voting rights at that time 25.2% 24.5%* B. Braun 24.5% Free Float 5.2% 75.5% Landeskrankenhilfe Strategic Investors 5.4% 25.1% Ingeborg Münch Asklepios 14.6% Eugen Münch/HCM SE * Shareho
Slide 12: IR contact
Appendix IR contact Contact Julian Schmitt Head of Investor Relations & Treasury tel +49 9771 65 1536 email ir@rhoen-klinikum-ag.com RHÖN-KLINIKUM AG – Appendix 12